![Workflow for TMB assessment using the FoundationOne CDx assay [63].... | Download Scientific Diagram Workflow for TMB assessment using the FoundationOne CDx assay [63].... | Download Scientific Diagram](https://www.researchgate.net/publication/334081089/figure/fig2/AS:774610417090560@1561692923137/Workflow-for-TMB-assessment-using-the-FoundationOne-CDx-assay-63-ExAC-Exome.png)
Workflow for TMB assessment using the FoundationOne CDx assay [63].... | Download Scientific Diagram
![FDA Approves Foundation Medicine's FoundationOne CDx™, the First and Only Comprehensive Genomic Profiling Test for All Solid Tumors Incorporating Multiple Companion Diagnostics | Business Wire FDA Approves Foundation Medicine's FoundationOne CDx™, the First and Only Comprehensive Genomic Profiling Test for All Solid Tumors Incorporating Multiple Companion Diagnostics | Business Wire](https://mms.businesswire.com/media/20171130006320/en/627351/5/FMI_lockup%C2%AE_left_fire_RGB300ppi_For_BW.jpg)
FDA Approves Foundation Medicine's FoundationOne CDx™, the First and Only Comprehensive Genomic Profiling Test for All Solid Tumors Incorporating Multiple Companion Diagnostics | Business Wire
![Foundation Medicine on X: "Now FDA approved as a companion diagnostic for PIQRAY® (alpelisib) to identify PIK3CA mutations, FoundationOne®CDx* may help match even more patients to approved treatments. Learn more: https://t.co/8lbnBl0RPX *Rx Foundation Medicine on X: "Now FDA approved as a companion diagnostic for PIQRAY® (alpelisib) to identify PIK3CA mutations, FoundationOne®CDx* may help match even more patients to approved treatments. Learn more: https://t.co/8lbnBl0RPX *Rx](https://pbs.twimg.com/media/EK-BgfIWsAIYRXm.png)
Foundation Medicine on X: "Now FDA approved as a companion diagnostic for PIQRAY® (alpelisib) to identify PIK3CA mutations, FoundationOne®CDx* may help match even more patients to approved treatments. Learn more: https://t.co/8lbnBl0RPX *Rx
![Foundation Medicine and Pfizer Announce Broad Partnership to Develop Companion Diagnostics for Pfizer's Oncology Portfolio | Business Wire Foundation Medicine and Pfizer Announce Broad Partnership to Develop Companion Diagnostics for Pfizer's Oncology Portfolio | Business Wire](https://mms.businesswire.com/media/20180116005430/en/627351/23/FMI_lockup%C2%AE_left_fire_RGB300ppi_For_BW.jpg)